Efficacy and Safety of the Ketogenic Diet for Mitochondrial Disease With Epilepsy: A Prospective, Open-labeled, Controlled Study

BACKGROUND: The ketogenic diet (KD) is increasingly used to treat drug-resistant epilepsy because of its favorable effect on seizure reduction. Patients with mitochondrial diseases tend to experience seizures. Therefore, this study aimed to test the efficacy of the KD on participants with mitochondr...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Lijuan, Li, Hua, Zhong, Jianmin, Yang, Liming, Chen, Guohong, Wang, Dong, Zheng, Guo, Han, Hong, Han, Xiong, Long, Yiqin, Wang, Xu, Liang, Jianmin, Yu, Mei, Shen, Xiaoyun, Fan, Mengke, Fang, Fang, Liao, Jianxiang, Sun, Dan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9377015/
https://www.ncbi.nlm.nih.gov/pubmed/35979062
http://dx.doi.org/10.3389/fneur.2022.880944

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9377015/
https://www.ncbi.nlm.nih.gov/pubmed/35979062
http://dx.doi.org/10.3389/fneur.2022.880944

Ejemplares similares